These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18634979)

  • 21. Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.
    Puri R; Nissen SE; Shao M; Elshazly MB; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2220-2228. PubMed ID: 27515380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
    Bayturan O; Kapadia S; Nicholls SJ; Tuzcu EM; Shao M; Uno K; Shreevatsa A; Lavoie AJ; Wolski K; Schoenhagen P; Nissen SE
    J Am Coll Cardiol; 2010 Jun; 55(24):2736-42. PubMed ID: 20538166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery calcification and changes in atheroma burden in response to established medical therapies.
    Nicholls SJ; Tuzcu EM; Wolski K; Sipahi I; Schoenhagen P; Crowe T; Kapadia SR; Hazen SL; Nissen SE
    J Am Coll Cardiol; 2007 Jan; 49(2):263-70. PubMed ID: 17222740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Terashima M; Michishita I;
    Coron Artery Dis; 2012 Jun; 23(4):239-44. PubMed ID: 22441135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.
    Schukro C; Syeda B; Yahya N; Gessl A; Holy EW; Pichler P; Derntl M; Glogar D
    J Diabetes Complications; 2007; 21(6):381-6. PubMed ID: 17967711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.
    Nicholls SJ; Sipahi I; Schoenhagen P; Wisniewski L; Churchill T; Crowe T; Goormastic M; Wolski K; Tuzcu EM; Nissen SE;
    Am Heart J; 2006 Jul; 152(1):67-74. PubMed ID: 16824833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling.
    Fujii K; Carlier SG; Mintz GS; Wijns W; Colombo A; Böse D; Erbel R; de Ribamar Costa J; Kimura M; Sano K; Costa RA; Lui J; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2005 Dec; 96(11):1476-83. PubMed ID: 16310425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between arterial remodelling and serial changes in coronary atherosclerosis by intravascular ultrasound: an analysis of the IBIS-4 study.
    Koskinas KC; Maldonado R; Garcia-Garcia HM; Yamaji K; Taniwaki M; Ueki Y; Otsuka T; Zanchin C; Karagiannis A; Radu Juul Jensen MD; Losdat S; Zaugg S; Windecker S; Räber L
    Eur Heart J Cardiovasc Imaging; 2021 Aug; 22(9):1054-1062. PubMed ID: 32929461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Crowe T; Kapadia S; Nissen SE
    Am Heart J; 2006 Sep; 152(3):544-50. PubMed ID: 16923429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.
    Sipahi I; Tuzcu EM; Schoenhagen P; Nicholls SJ; Ozduran V; Kapadia S; Nissen SE
    Eur Heart J; 2006 Jul; 27(14):1664-70. PubMed ID: 16524891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
    Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur J Prev Cardiol; 2013 Apr; 20(2):209-17. PubMed ID: 22345692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
    Brener SJ; Ivanc TB; Hu T
    J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
    Berry C; L'Allier PL; Grégoire J; Lespérance J; Levesque S; Ibrahim R; Tardif JC
    Circulation; 2007 Apr; 115(14):1851-7. PubMed ID: 17389269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
    Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
    Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
    Hartmann M; von Birgelen C; Mintz GS; Stoel MG; Eggebrecht H; Wieneke H; Fahy M; Neumann T; van der Palen J; Louwerenburg HW; Verhorst PM; Erbel R
    J Am Coll Cardiol; 2006 Aug; 48(3):446-52. PubMed ID: 16875967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.
    Du R; Zhang RY; Lu L; Shen Y; Pu LJ; Zhu ZB; Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
    Cardiovasc Diabetol; 2018 Nov; 17(1):149. PubMed ID: 30482197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hypertension on coronary remodeling patterns in angiographically normal or minimally atherosclerotic coronary arteries: an intravascular ultrasound study.
    Candemir B; Ertas FS; Ozdol C; Kaya CT; Kilickap M; Akyurek O; Atmaca Y; Kumbasar D; Erol C
    Clin Exp Hypertens; 2012; 34(6):432-8. PubMed ID: 22502594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.